Gender Dysphoria clinical trials at UCSF

1 research study open to eligible people

Gender dysphoria occurs when a person's gender identity does not match their physical appearance. UCSF conducts research to examine how a special device might minimize scar formation after gender-affirming chest surgery. This study could lead to enhanced methods for post-surgery care.

Showing trials for

  • Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

    open to eligible people ages 19 years and up

    The goal of this randomized, prospective, interventional clinical trial is to evaluate the use of Brijjit® in reducing the incidence of hypertrophic scarring in individuals undergoing gender-affirming bilateral double incision mastectomies at a single-institution, single-surgeon site (Esther A. Kim, MD). Patients will serve as a self-control (one side of the chest receives intervention, the other serves as a control). Primary endpoints include scar appearance and quality. Secondary endpoints include patient perception of the scar using the Patient and Observer Scar Assessment Scale (POSAS). Participants will be taught how to apply Brijjit® at home if any units fall off before 6 weeks postop.

    San Francisco, California

Our lead scientists for Gender Dysphoria research studies include .

Last updated: